Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

108 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multicenter evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis: A prospective non-interventional study.
Burghaus S, Drazic P, Wölfler M, Mechsner S, Zeppernick M, Meinhold-Heerlein I, Mueller MD, Rothmund R, Vigano P, Becker CM, Zondervan KT, Beckmann MW, Fasching PA, Berner-Gatz S, Grünewald FS, Hund M, Kastner P, Klammer M, Laubender RP, Wegmeyer H, Wienhues-Thelen UH, Renner SP. Burghaus S, et al. Among authors: meinhold heerlein i. Int J Gynaecol Obstet. 2024 Jan;164(1):305-314. doi: 10.1002/ijgo.15062. Epub 2023 Aug 28. Int J Gynaecol Obstet. 2024. PMID: 37635683 Free article.
QS ENDO Pilot - A Study by the Stiftung Endometrioseforschung (SEF) on the Quality of Care Provided to Patients with Endometriosis in Certified Endometriosis Centers in the DACH Region.
Meinhold-Heerlein I, Zeppernick M, Wölfler MM, Janschek E, Bornemann S, Holtmann L, Oehmke F, Salehin D, Scheible CM, Brandes I, Vingerhagen-Pethick S, Cornelius CP, Boosz A, Krämer B, Sillem M, Bühler K, Keckstein J, Schweppe KW, Zeppernick F; AG QS Endo of the Stiftung Endometrioseforschung (SEF). Meinhold-Heerlein I, et al. Geburtshilfe Frauenheilkd. 2023 May 23;83(7):835-842. doi: 10.1055/a-2061-6845. eCollection 2023 Jul. Geburtshilfe Frauenheilkd. 2023. PMID: 37404976 Free PMC article.
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.
Moore KN, Angelergues A, Konecny GE, García Y, Banerjee S, Lorusso D, Lee JY, Moroney JW, Colombo N, Roszak A, Tromp J, Myers T, Lee JW, Beiner M, Cosgrove CM, Cibula D, Martin LP, Sabatier R, Buscema J, Estévez-García P, Coffman L, Nicum S, Duska LR, Pignata S, Gálvez F, Wang Y, Method M, Berkenblit A, Bello Roufai D, Van Gorp T; Gynecologic Oncology Group Partners and the European Network of Gynaecological Oncological Trial Groups. Moore KN, et al. N Engl J Med. 2023 Dec 7;389(23):2162-2174. doi: 10.1056/NEJMoa2309169. N Engl J Med. 2023. PMID: 38055253 Clinical Trial.
108 results